In fact, both SR4 and niclosamide, independently of BRAF or NRAS mutational status, promote energetic stress in melanoma cells by uncoupling mitochondrial OXPHOS, reducing intracellular ATP levels and consequently promoting the activation of the metabolic tumor suppressor AMP-activated kinase (AMPK) and the inhibition of mTOR pathway. Here, BRAF is linked to melanoma.